$PMDI
PSYCHEMEDICS CORP

2020 Q1 Form 10-Q Financial Statement

#000117184320003761 Filed on May 15, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1 2018 Q4
Revenue $7.537M $9.822M $9.936M
YoY Change -23.26% -10.18% 1.8%
Cost Of Revenue $4.809M $5.414M $5.200M
YoY Change -11.17% -2.97% 4.42%
Gross Profit $2.728M $4.408M $4.733M
YoY Change -38.11% -17.68% -0.92%
Gross Profit Margin 36.19% 44.88% 47.63%
Selling, General & Admin $2.639M $3.044M $2.740M
YoY Change -13.3% -1.49% 10.48%
% of Gross Profit 96.74% 69.06% 57.89%
Research & Development $331.0K $420.0K $460.0K
YoY Change -21.19% 16.99% 31.43%
% of Gross Profit 12.13% 9.53% 9.72%
Depreciation & Amortization $610.0K $764.0K $760.0K
YoY Change -20.16% 1.46% 5.56%
% of Gross Profit 22.36% 17.33% 16.06%
Operating Expenses $2.970M $3.464M $3.210M
YoY Change -14.26% 0.43% 13.43%
Operating Profit -$242.0K $944.0K $1.528M
YoY Change -125.64% -50.47% -21.52%
Interest Expense -$70.00K $17.00K $0.00
YoY Change -511.76% -39.29% -100.0%
% of Operating Profit 1.8% 0.0%
Other Income/Expense, Net -$73.00K $26.00K
YoY Change -380.77% -18.75%
Pretax Income -$315.0K $970.0K $1.520M
YoY Change -132.47% -49.95% -23.62%
Income Tax -$156.0K $343.0K $640.0K
% Of Pretax Income 35.36% 42.11%
Net Earnings -$159.0K $627.0K $881.0K
YoY Change -125.36% -49.88% -62.51%
Net Earnings / Revenue -2.11% 6.38% 8.87%
Basic Earnings Per Share -$0.03 $0.11 $0.16
Diluted Earnings Per Share -$0.03 $0.11 $0.16
COMMON SHARES
Basic Shares Outstanding 5.517M 5.507M
Diluted Shares Outstanding 5.517M 5.538M

Balance Sheet

Concept 2020 Q1 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.330M $7.140M $7.970M
YoY Change -25.35% -13.77% -2.45%
Cash & Equivalents $5.331M $3.226M $4.069M
Short-Term Investments $3.910M $3.910M
Other Short-Term Assets $1.890M $1.200M $1.070M
YoY Change 57.5% 0.0% -11.57%
Inventory
Prepaid Expenses
Receivables $3.558M $5.131M $4.829M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $10.78M $13.47M $13.87M
YoY Change -20.0% -13.32% 0.04%
LONG-TERM ASSETS
Property, Plant & Equipment $10.89M $9.556M $10.18M
YoY Change 13.91% -15.35% -13.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $936.0K $901.0K $927.0K
YoY Change 3.88% 0.45% 11.42%
Total Long-Term Assets $14.43M $12.06M $11.10M
YoY Change 19.71% -1.07% -12.17%
TOTAL ASSETS
Total Short-Term Assets $10.78M $13.47M $13.87M
Total Long-Term Assets $14.43M $12.06M $11.10M
Total Assets $25.21M $25.53M $24.97M
YoY Change -1.25% -7.93% -5.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.234M $378.0K $682.0K
YoY Change 226.46% 15.6% 71.36%
Accrued Expenses $2.113M $2.627M $2.962M
YoY Change -19.57% -32.43% 3.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $680.0K $416.0K $416.0K
YoY Change 63.46% -56.53% -56.53%
Total Short-Term Liabilities $4.913M $4.371M $4.060M
YoY Change 12.4% -15.49% -3.91%
LONG-TERM LIABILITIES
Long-Term Debt $1.780M $1.109M $1.212M
YoY Change 60.5% -49.15% -49.92%
Other Long-Term Liabilities $2.210M $650.0K
YoY Change 240.0%
Total Long-Term Liabilities $1.780M $1.109M $1.212M
YoY Change 60.5% -49.15% -49.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.913M $4.371M $4.060M
Total Long-Term Liabilities $1.780M $1.109M $1.212M
Total Liabilities $9.402M $7.036M $6.227M
YoY Change 33.63% -17.78% -21.06%
SHAREHOLDERS EQUITY
Retained Earnings -$4.906M -$1.690M -$1.326M
YoY Change 190.3% 0.3% -37.25%
Common Stock $32.44M $31.71M $31.55M
YoY Change 2.31% 1.68% 1.61%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.08M $10.08M $10.08M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares $668.0K $668.0K $668.0K
Shareholders Equity $15.81M $18.49M $18.75M
YoY Change
Total Liabilities & Shareholders Equity $25.21M $25.53M $24.97M
YoY Change -1.25% -7.93% -5.79%

Cashflow Statement

Concept 2020 Q1 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$159.0K $627.0K $881.0K
YoY Change -125.36% -49.88% -62.51%
Depreciation, Depletion And Amortization $610.0K $764.0K $760.0K
YoY Change -20.16% 1.46% 5.56%
Cash From Operating Activities -$413.0K $368.0K $3.920M
YoY Change -212.23% -73.83% 93.1%
INVESTING ACTIVITIES
Capital Expenditures $401.0K $21.00K -$150.0K
YoY Change 1809.52% -85.42% -46.43%
Acquisitions
YoY Change
Other Investing Activities $7.000K -$16.00K -$4.070M
YoY Change -143.75% -121.62% 20250.0%
Cash From Investing Activities -$333.0K -$112.0K -$4.220M
YoY Change 197.32% -48.62% 1306.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.162M -1.095M -2.020M
YoY Change 6.12% 3.01% -287.04%
NET CHANGE
Cash From Operating Activities -413.0K 368.0K 3.920M
Cash From Investing Activities -333.0K -112.0K -4.220M
Cash From Financing Activities -1.162M -1.095M -2.020M
Net Change In Cash -1.952M -839.0K -2.320M
YoY Change 132.66% -771.2% -182.56%
FREE CASH FLOW
Cash From Operating Activities -$413.0K $368.0K $3.920M
Capital Expenditures $401.0K $21.00K -$150.0K
Free Cash Flow -$814.0K $347.0K $4.070M
YoY Change -334.58% -72.5% 76.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 pmd Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
145000
CY2020Q1 pmd Payments Of Equipment Financing
PaymentsOfEquipmentFinancing
169000
CY2019Q1 pmd Payments Of Equipment Financing
PaymentsOfEquipmentFinancing
104000
CY2020Q1 pmd Rightofuse Asset Amortization
RightofuseAssetAmortization
264000
CY2020Q1 pmd Income Tax Expense Benefit Adjustment From Cares Act
IncomeTaxExpenseBenefitAdjustmentFromCaresAct
-100000
CY2020Q1 pmd Increase Decrease In Accrued Expenses And Accrued Income Taxes
IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes
-1783000
CY2019Q1 pmd Increase Decrease In Accrued Expenses And Accrued Income Taxes
IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes
-333000
CY2020Q1 pmd Increase Decrease In Operating Lease Rou Assets And Liabilities
IncreaseDecreaseInOperatingLeaseROUAssetsAndLiabilities
-238000
CY2019Q1 pmd Increase Decrease In Operating Lease Rou Assets And Liabilities
IncreaseDecreaseInOperatingLeaseROUAssetsAndLiabilities
-256000
CY2019Q1 pmd Rightofuse Asset Amortization
RightofuseAssetAmortization
256000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1234000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
617000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3558000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3780000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2113000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3577000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14903000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16197000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1647000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1624000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32412000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32249000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
163000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
158000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
163000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
158000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
46000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
605000
CY2020Q1 us-gaap Assets
Assets
25210000
CY2019Q4 us-gaap Assets
Assets
27531000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
10778000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
12851000
CY2020Q1 us-gaap Cash
Cash
5331000
CY2019Q4 us-gaap Cash
Cash
7283000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7283000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4069000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5331000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3226000
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1952000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-843000
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6185000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6185000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6185000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6185000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
31000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
31000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-182000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
579000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4809000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5414000
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
495000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
550000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
610000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
764000
CY2020Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0; text-align: right"></td> <td style="width: 0.25in"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">14.</div></div></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Accounting Pronouncements Issued But <div style="display: inline; font-style: italic; font: inherit;">Not</div> Yet Effective</div></td> </tr> </table> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.25in"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the quarter there were <div style="display: inline; font-style: italic; font: inherit;">no</div> recent accounting pronouncements affecting the Company.</div></div>
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
101000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
137000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
23000
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
993000
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
991000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-44000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-4000
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-94000
CY2019Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1533000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1915000
CY2020Q1 us-gaap Gross Profit
GrossProfit
2728000
CY2019Q1 us-gaap Gross Profit
GrossProfit
4408000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-315000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
970000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-156000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
343000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
169000
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
432000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
570000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-306000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-222000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
302000
CY2020Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
55000
CY2019Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
48000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
17000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3375000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
582000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
584000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
619000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
644000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
801000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
275000
CY2020Q1 us-gaap Liabilities
Liabilities
9402000
CY2019Q4 us-gaap Liabilities
Liabilities
10711000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25210000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27531000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4913000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5835000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
2460000
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
680000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
678000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
305000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
294000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
664000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
688000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
509000
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1780000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1951000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1162000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1095000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-333000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-112000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-413000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
368000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-159000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
627000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-242000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
3464000
CY2020Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
386000
CY2019Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
4000
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
2970000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
944000
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
306000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3100000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
886000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
963000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2214000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2375000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
238000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
260000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2611000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2875000
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y73D
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
936000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
943000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-23000
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-48000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-23000
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-48000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
55000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-73000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26000
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
7000
CY2019Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-16000
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
993000
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
991000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
401000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1889000
CY2020Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
65000
CY2019Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
107000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
873000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
873000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1788000
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
140000
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10885000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10862000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
331000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
420000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4906000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3754000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7537000
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9822000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1558000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1106000
CY2019Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1129000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
163000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
158000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
246000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
14.38
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
3000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.37
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
584000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
581000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.94
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.93
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y219D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y328D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y219D
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
16820000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
15808000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
18747000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
18493000
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
668000
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
668000
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
10082000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10082000
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
31000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5517000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5538000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5517000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5507000

Files In Submission

Name View Source Status
0001171843-20-003761-index-headers.html Edgar Link pending
0001171843-20-003761-index.html Edgar Link pending
0001171843-20-003761.txt Edgar Link pending
0001171843-20-003761-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10q_051520p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pmd-20200331.xml Edgar Link completed
pmd-20200331.xsd Edgar Link pending
pmd-20200331_cal.xml Edgar Link unprocessable
pmd-20200331_def.xml Edgar Link unprocessable
pmd-20200331_lab.xml Edgar Link unprocessable
pmd-20200331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending